Autologous peripheral blood stem cell mobilization and apheresis in pediatric patients with cancer: A single‐center report of 64 procedures

Author:

Yazal Erdem Arzu1ORCID,Özyörük Derya1ORCID,Ok Bozkaya İkbal1ORCID,Çakmakcı Selma1ORCID,Emir Suna2ORCID,Demir Hacı Ahmet3ORCID,Özgüner Habibe Meltem4ORCID,Ergürhan İlhan İnci1ORCID,Özbek Namık Yaşar1ORCID

Affiliation:

1. Department of Pediatric Hematology and Oncology Ankara Bilkent City Hospital, University of Health Sciences Turkey Ankara Turkey

2. Department of Pediatrics Atılım University Faculty of Medicine Ankara Turkey

3. Department of Pediatric Hematology and Oncology Memorial Private Hospital Ankara Turkey

4. Department of Histology and Embriology Ankara Yıldırım Beyazıt University Ankara Turkey

Abstract

AbstractBackgroundThe published experience concerning autologous peripheral blood stem cell collection in children is very limited.MethodsThe data of pediatric patients who underwent autologous stem cell mobilization and apheresis between January 2011 and April 2020 were analyzed retrospectively.ResultsWe studied retrospectively 64 mobilization and apheresis procedures in 48 pediatric patients (34 males, 14 females), mean age of 7.31 ± 5.38 (range, 1.5–19.7) years, the underlying disease was mostly neuroblastoma (NBL). The body weight of 21 patients (43.75%) was 15 kg or less. The targeted autologous peripheral stem cell apheresis (APSCA) was successfully achieved in 98% of patients. Neuroblastoma patients were younger than the rest of the patients and underwent apheresis after receiving fewer chemotherapy cycles than others and all of them mobilized within the first session successfully. Plerixafor was added to mobilization in nine heavily pretreated patients (18.7%), median two doses (range, 1–4 doses). 11 patients (22.9%) underwent radiotherapy (RT) before mobilization with doses of median 24 Gy (range, 10.8–54.0 Gy). Patients with RT were older at the time of apheresis and had received more chemotherapy courses than patients without RT. As a result, patients with a history of RT had significantly lower peripheral CD34+ cells and CD34+ yields than those without RT. In 17 patients (35.4%), 22 different complications were noted. The most common complications were catheter‐related infections (n:10, 20.8%), followed by catheter‐related thrombosis in eight patients (16.7%).ConclusionsPatients who had far less therapy before apheresis were more likely to mobilize successfully. Our study provides a detailed practice approach including complications during APSCA aiming to increase the success rates of apheresis in transplantation centers.

Publisher

Wiley

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3